Maxim Group Begins Coverage on SBC Medical Group (NASDAQ:SBC)

Analysts at Maxim Group assumed coverage on shares of SBC Medical Group (NASDAQ:SBC) in a research report issued on Wednesday, MarketBeat reports. The firm set a “buy” rating on the stock.

A number of other equities analysts have also issued reports on the company. Wall Street Zen raised SBC Medical Group from a “hold” rating to a “buy” rating in a report on Saturday, September 20th. Weiss Ratings reissued a “sell (d)” rating on shares of SBC Medical Group in a research note on Wednesday. One equities research analyst has rated the stock with a Buy rating and one has assigned a Sell rating to the company. According to MarketBeat, the company has a consensus rating of “Hold” and an average target price of $9.00.

SBC Medical Group Stock Performance

Shares of SBC Medical Group stock traded up $0.07 during trading on Wednesday, hitting $3.15. 29,969 shares of the stock were exchanged, compared to its average volume of 63,777. The company has a debt-to-equity ratio of 0.03, a quick ratio of 3.95 and a current ratio of 3.98. SBC Medical Group has a 12 month low of $2.62 and a 12 month high of $7.99. The stock’s fifty day moving average is $4.09 and its 200 day moving average is $4.23. The stock has a market cap of $327.22 million, a PE ratio of 9.84 and a beta of 1.27.

SBC Medical Group (NASDAQ:SBC) last posted its earnings results on Wednesday, August 13th. The company reported $0.02 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.14 by ($0.12). SBC Medical Group had a net margin of 17.71% and a return on equity of 20.76%. The firm had revenue of $43.36 million for the quarter, compared to analyst estimates of $44.71 million. As a group, sell-side analysts anticipate that SBC Medical Group will post 5.02 EPS for the current year.

Hedge Funds Weigh In On SBC Medical Group

Several institutional investors and hedge funds have recently added to or reduced their stakes in the company. Geode Capital Management LLC purchased a new stake in shares of SBC Medical Group in the second quarter valued at $455,000. SBI Securities Co. Ltd. increased its stake in SBC Medical Group by 227.3% in the 2nd quarter. SBI Securities Co. Ltd. now owns 54,177 shares of the company’s stock valued at $251,000 after buying an additional 37,623 shares during the period. New York State Common Retirement Fund acquired a new stake in shares of SBC Medical Group during the 2nd quarter valued at $104,000. Finally, XTX Topco Ltd acquired a new stake in shares of SBC Medical Group during the 2nd quarter valued at $64,000. 60.82% of the stock is currently owned by hedge funds and other institutional investors.

SBC Medical Group Company Profile

SBC Medical Group Holdings Incorporated, through its subsidiaries, provides services to support the operation of clinics which deliver specialized medical services in the areas of cosmetic medicine, esthetic dentistry and Androgenetic Alopecia or AGA, primarily in Japan and centered on the SBC Shonan Beauty Clinic Brand.